Skip to main content

Cytokinetics, Incorporated (NASDAQ: CYTK) Investor Securities Class Action Lawsuit 09/18/2025

  • If you purchased a significant amount of shares of Cytokinetics, Incorporated (NASDAQ: CYTK) between December 27, 2023, to May 6, 2025, and / or if you purchased any NASDAQ: CYTK shares prior to December 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: November 17, 2025. NASDAQ: CYTK investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 18, 2025 - An investor in shares of Cytokinetics, Incorporated (NASDAQ: CYTK) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Cytokinetics, Incorporated in connection with certain allegedly false and misleading statements made between December 27, 2023, to May 6, 2025.   San Francisco, C...



You must register (for free) or login to view the entire case.